BD BBL Sensi Disc Ceftaroline test discs recalled for accuracy failures
Becton Dickinson is recalling BD BBL Sensi Disc Ceftaroline test discs due to potential accuracy and quality control failures in antibiotic susceptibility testing. Incorrect test results may delay diagnosis and lead to inappropriate antibiotic selection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a diagnostic test product with potential for incorrect test results. No illnesses or injuries have been reported. The recall addresses theoretical risk of diagnostic delay and inappropriate antibiotic selection, which qualifies as a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Becton Dickinson & Co. is recalling BD BBL Sensi Disc Ceftaroline - 30 ug antibiotic susceptibility test discs. The recalled product is used in laboratory settings for semi-quantitative in vitro susceptibility testing. A total of 2,363,168 units have been distributed both domestically and internationally.
The discs may experience reproducibility, accuracy, and quality control failures when used in antibiotic susceptibility testing for Haemophilus influenzae. These failures could result in inaccurate test outcomes, which may lead to diagnostic delays, inappropriate antibiotic selection, or extended duration of antibiotic exposure.
Clinical laboratories and healthcare facilities that use these test discs are affected. The recalled lots include Catalog Number 232231, Lots 3116030 and 3212690 (UDI-DI 30382902322314).
The recalled product
- Product
- BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231¿
- Manufacturer
- Becton Dickinson & Co.
- Affected units
- 2,363,168
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Catalog No. 232231¿ UDI-DI 30382902322314 Lots 3116030 3212690
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Becton Dickinson & Co. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Becton Dickinson & Co.
See all →- ModerateBD GasPak EZ Campy Pouch System Recall for Below-Specification Gas Production
FDA (Devices) · 2026-05-06
- ModerateBD GasPak EZ CO2 Pouch System gas generating sachets underperforming
FDA (Devices) · 2026-05-06
- ModerateLaboratory cuvette arrays recalled over barcodes the analyser cannot read
FDA (Devices) · 2025-11-19
- HighAutomated microbiology systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
- HighBlood culture systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
Same hazard · test inaccuracy
See all →- ModerateLeadCare II Blood Lead Test Kit Recall for Inaccurate Results
FDA (Devices) · 2026-04-29
- ModerateOrtho Clinical Diagnostics Total Bili-Alkp XT Reagent Recall
FDA (Devices) · 2025-06-04
- ModerateORTHO CLINICAL DIAGNOSTICS VITROS BUN Reagent Recall Nationwide
FDA (Devices) · 2025-06-04
- HighSiemens Atellica CH Cuvette Segment manufacturing defect may impact lab test accuracy
FDA (Devices) · 2024-11-27
- HighRandox Clinical Chemistry Calibration Serum Recalled for Measurement Bias
FDA (Devices) · 2024-05-15